Text Size

Implantable Antenna Sensors for Continuous Glucose Monitoring

This study has been completed.
Sponsor:
Collaborator:
Juvenile Diabetes Research Foundation
Information provided by:
University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT00596323
First received: January 7, 2008
Last updated: December 1, 2009
Last verified: December 2009
History of Changes
  Purpose

The researchers' long-term goal is to develop a small implantable device that can continually monitor glucose levels. This will be an antenna. Changes in the glucose levels in will affect the antenna signals and those can be used to predict the patient's glucose levels.


Condition
Type 1 Diabetes Mellitus

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Implantable Antenna Sensors for Continuous Glucose Monitoring

Resource links provided by NLM:

Drug Information available for: Dextrose
U.S. FDA Resources

Further study details as provided by University of Alabama at Birmingham:

Enrollment: 10
Study Start Date: June 2007
Study Completion Date: June 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Detailed Description:

Our goal is to develop a small size implantable device that can continually monitor glucose levels. The scientific objective of this application is to examine the efficacy of using implantable antennas to measure the glucose levels. The central hypothesis of this application is that the changes in the glucose levels in the medium surrounding the antenna will affect the antenna parameters such as input impedance and resonance frequency, and these changes can be used to predict the patient's glucose levels. We have formulated this hypothesis on the basis of our preliminary data, which will be detailed later, in the Preliminary Studies section. The rationale for the proposed research is that, once the correlation between the glucose levels and antenna parameters are determined, the design of a miniaturized long term glucose monitoring device will become a reality.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Healthy adults

Criteria

Inclusion Criteria:

  • Healthy adult able to give a blood sample

Exclusion Criteria:

  • Adults with diabetes or other glycemic or hematologic disorders.
  • Sick adults
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00596323

Locations
United States, Alabama
University of Alabama Children's Hospital
Birmingham, Alabama, United States, 35213
Sponsors and Collaborators
University of Alabama at Birmingham
Juvenile Diabetes Research Foundation
Investigators
Study Director: Elaine Moreland, MD University of Alabama at Birmingham
  More Information

No publications provided

Responsible Party: Elaine Moreland MD, UAB
ClinicalTrials.gov Identifier: NCT00596323     History of Changes
Other Study ID Numbers: X070207013
Study First Received: January 7, 2008
Last Updated: December 1, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by University of Alabama at Birmingham:
antenna
continuous glucose monitoring
electromagnetic

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 1
Glucose Metabolism Disorders
Metabolic Diseases
 Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on May 22, 2013